[go: up one dir, main page]

AU2003204353A1 - Methods and compositions for enhancing immune response and for the production of in vitro mabs - Google Patents

Methods and compositions for enhancing immune response and for the production of in vitro mabs

Info

Publication number
AU2003204353A1
AU2003204353A1 AU2003204353A AU2003204353A AU2003204353A1 AU 2003204353 A1 AU2003204353 A1 AU 2003204353A1 AU 2003204353 A AU2003204353 A AU 2003204353A AU 2003204353 A AU2003204353 A AU 2003204353A AU 2003204353 A1 AU2003204353 A1 AU 2003204353A1
Authority
AU
Australia
Prior art keywords
mabs
vitro
compositions
production
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2003204353A
Other versions
AU2003204353B2 (en
Inventor
Giulio F Paciotti
Lawrence Tamarkin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytimmune Sciences Inc
Original Assignee
Cytimmune Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU14548/99A external-priority patent/AU757357B2/en
Application filed by Cytimmune Sciences Inc filed Critical Cytimmune Sciences Inc
Priority to AU2003204353A priority Critical patent/AU2003204353B2/en
Publication of AU2003204353A1 publication Critical patent/AU2003204353A1/en
Application granted granted Critical
Publication of AU2003204353B2 publication Critical patent/AU2003204353B2/en
Priority to AU2006235956A priority patent/AU2006235956B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2003204353A 1997-11-10 2003-05-23 Methods and compositions for enhancing immune response and for the production of in vitro mabs Ceased AU2003204353B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2003204353A AU2003204353B2 (en) 1997-11-10 2003-05-23 Methods and compositions for enhancing immune response and for the production of in vitro mabs
AU2006235956A AU2006235956B2 (en) 1997-11-10 2006-11-10 Methods and compositions for enhancing immune response and for the production of in vitro mabs

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US6515597P 1997-11-10 1997-11-10
US60/065155 1997-11-10
US7581198P 1998-02-24 1998-02-24
US60/075811 1998-02-24
US10745598P 1998-11-06 1998-11-06
US60/107455 1998-11-06
AU14548/99A AU757357B2 (en) 1997-11-10 1998-11-10 Methods and compositions for enhancing immune response and for the production of in vitro mabs
PCT/US1998/023957 WO1999024066A2 (en) 1997-11-10 1998-11-10 Methods and compositions for enhancing immune response and for the production of in vitro mabs
AU2003204353A AU2003204353B2 (en) 1997-11-10 2003-05-23 Methods and compositions for enhancing immune response and for the production of in vitro mabs

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU14548/99A Division AU757357B2 (en) 1997-11-10 1998-11-10 Methods and compositions for enhancing immune response and for the production of in vitro mabs

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2006235956A Division AU2006235956B2 (en) 1997-11-10 2006-11-10 Methods and compositions for enhancing immune response and for the production of in vitro mabs

Publications (2)

Publication Number Publication Date
AU2003204353A1 true AU2003204353A1 (en) 2003-06-19
AU2003204353B2 AU2003204353B2 (en) 2006-08-10

Family

ID=27370737

Family Applications (3)

Application Number Title Priority Date Filing Date
AU14548/99A Ceased AU757357B2 (en) 1997-11-10 1998-11-10 Methods and compositions for enhancing immune response and for the production of in vitro mabs
AU2003204353A Ceased AU2003204353B2 (en) 1997-11-10 2003-05-23 Methods and compositions for enhancing immune response and for the production of in vitro mabs
AU2006235956A Ceased AU2006235956B2 (en) 1997-11-10 2006-11-10 Methods and compositions for enhancing immune response and for the production of in vitro mabs

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU14548/99A Ceased AU757357B2 (en) 1997-11-10 1998-11-10 Methods and compositions for enhancing immune response and for the production of in vitro mabs

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2006235956A Ceased AU2006235956B2 (en) 1997-11-10 2006-11-10 Methods and compositions for enhancing immune response and for the production of in vitro mabs

Country Status (8)

Country Link
EP (1) EP1039933B8 (en)
JP (3) JP4588210B2 (en)
AT (1) ATE317269T1 (en)
AU (3) AU757357B2 (en)
CA (1) CA2309602C (en)
DE (1) DE69833455T2 (en)
NZ (1) NZ504292A (en)
WO (1) WO1999024066A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010055581A1 (en) 1994-03-18 2001-12-27 Lawrence Tamarkin Composition and method for delivery of biologically-active factors
US6407218B1 (en) 1997-11-10 2002-06-18 Cytimmune Sciences, Inc. Method and compositions for enhancing immune response and for the production of in vitro mabs
US7229841B2 (en) 2001-04-30 2007-06-12 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
EP1133994A1 (en) * 2000-03-11 2001-09-19 Biognostik Gesellschaft für biomolekulare Diagnostik mbH A method for reversing the immunosuppressive effects of the Melanoma Inhibitory Activity "MIA"
CA2448607C (en) * 2001-04-30 2013-01-22 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
WO2005065121A2 (en) 2003-12-02 2005-07-21 Cytimmune Sciences, Inc. Methods and compositions for the production of monoclonal antibodies
CN1960825A (en) * 2004-01-28 2007-05-09 细胞免疫科学公司 Functionalized colloidal metal compositions and methods
KR100836745B1 (en) * 2007-01-31 2008-06-10 (주)두비엘 HV vaccine and preparation method thereof
US8877156B2 (en) 2007-06-26 2014-11-04 New York University Contrast agents anchored by thiols on nanoparticles
US20090104114A1 (en) * 2007-09-21 2009-04-23 Cytimmune Sciences, Inc. Nanotherapeutic Colloidal Metal Compositions and Methods
CA2706700A1 (en) 2007-11-08 2009-05-14 Cytimmune Sciences, Inc. Compositions and methods for generating antibodies
JP5364310B2 (en) * 2008-07-14 2013-12-11 アルフレッサファーマ株式会社 Method for stabilizing microparticles to which reactive substances are bound, and reagent containing the microparticles

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57502090A (en) * 1980-07-18 1982-11-25
IL70686A (en) * 1983-01-20 1988-07-31 Suntory Ltd Mutant tumor cell lines for use in the preparation of hybridomas and the hybridomas obtained therefrom
JPS61104796A (en) * 1984-10-26 1986-05-23 Chemo Sero Therapeut Res Inst Preparation of monoclonal antibody
JPS62162963A (en) * 1986-01-10 1987-07-18 Sadao Shiosaka Specific antibody of low molecular material prepared by using metallic colloid particle as carrier and preparation thereof
WO1994021288A1 (en) * 1993-03-18 1994-09-29 Cytimmune Sciences, Inc. Composition and method for reducing toxicity of biologically-active factors
JPH07227299A (en) * 1994-02-14 1995-08-29 Kyoto Daiichi Kagaku:Kk Method for detecting specific base sequence of dna and device therefor
US5686578A (en) * 1994-08-05 1997-11-11 Immunomedics, Inc. Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
JPH09107980A (en) * 1995-08-17 1997-04-28 Japan Tobacco Inc New physiologically active protein
US6407218B1 (en) * 1997-11-10 2002-06-18 Cytimmune Sciences, Inc. Method and compositions for enhancing immune response and for the production of in vitro mabs
ATE320270T1 (en) * 1997-11-10 2006-04-15 Cytimmune Sciences Inc COMPOSITIONS AND METHODS FOR THE TARGETED DELIVERY OF BIOLOGICALLY ACTIVE FACTORS

Similar Documents

Publication Publication Date Title
AU6134698A (en) Fluoroelastomer compositions and methods of producing same
AUPQ419099A0 (en) Novel compositions and methods
AU7678196A (en) Methods and compositions for the delivery of monomeric proteins
ZA987537B (en) Stanol ester composition and production thereof.
AU8370298A (en) Process for preparation of soft magnetic composites and the composites prepared
AU3877700A (en) High protein edible compositions and method of preparing the same
AU3885301A (en) Anti-mycobacterium compositions and methods of preparing and using same
AU1398399A (en) The use of particles in the composition of cosmetic products
AU7116798A (en) Silicon greases and methods for their production
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
AU2003204353A1 (en) Methods and compositions for enhancing immune response and for the production of in vitro mabs
AU4057197A (en) Composition to aid in the forming of metal
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU1957797A (en) Zwitterionic compositions and methods as biological response modifiers
AU1703995A (en) Methods for the production of fungal spores and compositions thereof
AU7474100A (en) Methods and compositions for reducing immune response
AU7530898A (en) Process for the production of isomaltulose and other products
AU7134598A (en) Plant propagation compositions and methods
AU3923000A (en) Agp-1 fusion protein compositions and methods
AU3730497A (en) Compositions and articles of manufacture
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
AU6497799A (en) Methods and compositions to induce antitumor response
AU5456898A (en) Compositions and articles of manufacture
AU2171297A (en) Pharmaceutical compositions and methods for the manufacture thereof
AU7675198A (en) Sucralfate-containing composition and process for the preparation thereof